<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

27/07/2024 00:01
27/07/2024 02:22
26/07/2024 19:50
26/07/2024 18:50
26/07/2024 22:08
26/07/2024 23:34
27/07/2024 00:21
26/07/2024 11:22
26/07/2024 15:30
26/07/2024 23:33
27/07/2024 00:13
26/07/2024 22:40
26/07/2024 23:27
26/07/2024 11:00
26/07/2024 17:03
26/07/2024 14:07
26/07/2024 20:16
26/07/2024 21:32
27/07/2024 01:07
27/07/2024 00:31
26/07/2024 22:59
26/07/2024 13:23
27/07/2024 01:15
26/07/2024 21:38
26/07/2024 21:47
27/07/2024 00:30
27/07/2024 00:35
27/07/2024 02:41
26/07/2024 23:46
26/07/2024 23:48
26/07/2024 20:22
26/07/2024 16:45
26/07/2024 11:48
25/07/2024 07:27
26/07/2024 18:07
26/07/2024 20:55
25/07/2024 17:50
27/07/2024 01:36